Hinge Health, Inc. (HNGE)
NYSE: HNGE · Real-Time Price · USD
40.56
+1.37 (3.50%)
At close: Feb 18, 2026, 4:00 PM EST
40.56
0.00 (0.00%)
After-hours: Feb 18, 2026, 7:00 PM EST
Hinge Health Stock Forecast
Stock Price Forecast
The 16 analysts that cover Hinge Health stock have a consensus rating of "Strong Buy" and an average price target of $58.25, which forecasts a 43.61% increase in the stock price over the next year. The lowest target is $45 and the highest is $70.
Price Target: $58.25 (+43.61%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Hinge Health stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 6 | 6 |
| Buy | 9 | 9 | 9 | 9 | 10 | 10 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 15 | 15 | 15 | 15 | 17 | 17 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $65 → $53 | Strong Buy | Maintains | $65 → $53 | +30.67% | Feb 11, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $60 → $50 | Buy | Maintains | $60 → $50 | +23.27% | Feb 11, 2026 |
| Citizens | Citizens | Buy Reiterates $65 | Buy | Reiterates | $65 | +60.26% | Feb 11, 2026 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $65 → $50 | Buy | Maintains | $65 → $50 | +23.27% | Feb 11, 2026 |
| Barclays | Barclays | Buy Maintains $60 → $52 | Buy | Maintains | $60 → $52 | +28.21% | Feb 11, 2026 |
Financial Forecast
Revenue This Year
741.23M
from 587.86M
Increased by 26.09%
Revenue Next Year
874.21M
from 741.23M
Increased by 17.94%
EPS This Year
1.56
from -7.77
EPS Next Year
1.94
from 1.56
Increased by 24.81%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 782.6M | 960.8M | |||
| Avg | 741.2M | 874.2M | |||
| Low | 669.4M | 776.4M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 33.1% | 29.6% | |||
| Avg | 26.1% | 17.9% | |||
| Low | 13.9% | 4.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 2.04 | 2.53 | |||
| Avg | 1.56 | 1.94 | |||
| Low | 0.71 | 1.52 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | 62.4% | |||
| Avg | - | 24.8% | |||
| Low | - | -2.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.